ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced ...

The peptide synthesis market is a rapidly evolving segment of the biotechnology and pharmaceutical industries, playing a pivotal role in drug development, diagnostics, and research. Peptides, which ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

PEPperPRINT launches its next-generation peptide microarray platform, cLIFT; paves the way for innovative biomedical research applications: Heidelberg Thursday, June 12, 2025, 10: ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Myrio's PHOX2B PC-CAR T therapy gains FDA approval for human trials, promising innovative treatment for patients with ...

Scientists have mapped how over 140,000 mutations affect the formation of amyloid beta fibrils, offering an unprecedented look at early events in Alzheimer’s disease.

"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

Professor Nathan Gianneschi will receive the $10,000 Kabiller Young Investigator’s Award in Nanoscience and Nanomedicine for ...

Topline results from the chronic cohort of an ongoing phase 1b/2a clinical trial of an investigational therapeutic peptide, NVG-291, found the novel treatment led to increased electrical connectivity ...